Hyster-Yale (HY) EBIT (2016 - 2026)
Hyster-Yale filings provide 16 years of EBIT readings, the most recent being -$28.0 million for Q1 2026.
- Quarterly EBIT fell 231.46% to -$28.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$71.4 million through Mar 2026, down 139.17% year-over-year, with the annual reading at -$22.1 million for FY2025, 109.03% down from the prior year.
- EBIT hit -$28.0 million in Q1 2026 for Hyster-Yale, up from -$37.2 million in the prior quarter.
- Across five years, EBIT topped out at $95.6 million in Q2 2024 and bottomed at -$37.2 million in Q4 2025.
- Average EBIT over 5 years is $21.4 million, with a median of $21.3 million recorded in 2025.
- The largest annual shift saw EBIT crashed 690.32% in 2022 before it soared 474.52% in 2023.
- Hyster-Yale's EBIT stood at $19.8 million in 2022, then skyrocketed by 145.96% to $48.7 million in 2023, then tumbled by 33.68% to $32.3 million in 2024, then plummeted by 215.17% to -$37.2 million in 2025, then grew by 24.73% to -$28.0 million in 2026.
- Per Business Quant, the three most recent readings for HY's EBIT are -$28.0 million (Q1 2026), -$37.2 million (Q4 2025), and $2.3 million (Q3 2025).